Get started
WUXI APPTECWUXI APPTECWUXI APPTEC

WUXI APPTEC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

603259 chart


Full chart

Key facts today

WuXi AppTec has sold its cell and gene therapy unit, WuXi Advanced Therapies, and Oxford Genetics to U.S. private equity firm Altaris LLC. Financial details of the transactions were not disclosed.
Analyze the impactAnalyze the impact

603259 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪159.28 B‬ CNY
Dividend yield (indicated)
1.76%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪9.61 B‬ CNY
Revenue (FY)
‪40.04 B‬ CNY
Shares float
‪1.70 B‬
Beta (1Y)
1.40

Employees


Employees (FY)
‪41.12 K‬
Change (1Y)
‪−3.25 K‬ −7.31%
Revenue / Employee (1Y)
‪973.91 K‬ CNY
Net income / Employee (1Y)
‪233.65 K‬ CNY

About WUXI APPTEC


Sector
Health Technology
Headquarters
Shanghai
Founded
2000
Website
wuxiapptec.com.cn
ISIN
CNE1000031K4
FIGI
BBG00H5L2QD6
WuXi AppTec Co., Ltd. provides an integrated pharmaceutical platform for the research, development, and production of new drugs. It operates through the following business segments: Contract research organization (CRO) services, Contract manufacturing organization (CMO)/Contract development and manufacturing organization (CDMO) business, and Others. The CRO services segment includes laboratory services in China, laboratory services in the United States, and clinical research services. The company was founded by Ge Li, Ning Zhao, Xiao Zhong Liu, Zhao Hui Zhang, and Tao Lin on December 1, 2000 and is headquartered in Shanghai, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

603259 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 603259 is 55.92 CNY — it has increased by 0.34% in the past 24 hours. Watch WUXI APPTEC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange WUXI APPTEC stocks are traded under the ticker 603259.
603259 stock has risen by 0.80% compared to the previous week, the month change is a 8.54% rise, over the last year WUXI APPTEC has showed a −23.98% decrease.
We've gathered analysts' opinions on WUXI APPTEC future price: according to them, 603259 price has a max estimate of 96.12 CNY and a min estimate of 28.70 CNY. Watch 603259 chart and read a more detailed WUXI APPTEC stock forecast: see what analysts think of WUXI APPTEC and suggest that you do with its stocks.
603259 reached its all-time high on Jul 16, 2021 with the price of 172.49 CNY, and its all-time low was 11.02 CNY and was reached on May 8, 2018. View more price dynamics on 603259 chart.
See other stocks reaching their highest and lowest prices.
603259 stock is 4.17% volatile and has beta coefficient of 1.40. Track WUXI APPTEC stock price on the chart and check out the list of the most volatile stocks — is WUXI APPTEC there?
Today WUXI APPTEC has the market capitalization of ‪161.58 B‬, it has decreased by −3.97% over the last week.
Yes, you can track WUXI APPTEC financials in yearly and quarterly reports right on TradingView.
WUXI APPTEC is going to release the next earnings report on Mar 25, 2025. Keep track of upcoming events with our Earnings Calendar.
603259 earnings for the last quarter are 0.79 CNY per share, whereas the estimation was 0.84 CNY resulting in a −5.95% surprise. The estimated earnings for the next quarter are 1.10 CNY per share. See more details about WUXI APPTEC earnings.
WUXI APPTEC revenue for the last quarter amounts to ‪10.46 B‬ CNY, despite the estimated figure of ‪10.01 B‬ CNY. In the next quarter, revenue is expected to reach ‪11.54 B‬ CNY.
603259 net income for the last quarter is ‪2.29 B‬ CNY, while the quarter before that showed ‪2.30 B‬ CNY of net income which accounts for −0.20% change. Track more WUXI APPTEC financial stats to get the full picture.
Yes, 603259 dividends are paid annually. The last dividend per share was 0.99 CNY. As of today, Dividend Yield (TTM)% is 1.76%. Tracking WUXI APPTEC dividends might help you take more informed decisions.
WUXI APPTEC dividend yield was 1.35% in 2023, and payout ratio reached 30.08%. The year before the numbers were 1.05% and 28.25% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has ‪41.12 K‬ employees. See our rating of the largest employees — is WUXI APPTEC on this list?
Like other stocks, 603259 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WUXI APPTEC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So WUXI APPTEC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating WUXI APPTEC stock shows the neutral signal. See more of WUXI APPTEC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.